Copyright (c) 2016 AJC
This work is licensed under a Creative Commons Attribution 4.0 International License.
Effect of Acid and Base of Different Brands of Mefenamic Acid by UV Spectrophotometeric Method
Corresponding Author(s) : Safila Naveed
Asian Journal of Chemistry,
Vol. 28 No. 2 (2016): Vol 28 Issue 2
Abstract
Mefenamic acid belongs to class of drug NSAIDS (non-steroidal anti-inflammatory drugs). Mefenamic acid inhibits the synthesis and actions of prostaglandins and it also block the COX-1 and COX-2 or COX enzyme. The purpose of this research is to study the effect of acid and base by using UV spectrophotometry, on different brands of mefenamic acid under ICH guideline Q1A (R2). According to USP, mefenamic acid contains not less than 98 % and not more than 102 % of C15H15NO2 calculated on dried basis. The result concludes that when chosen brands of mefenamic acid i.e. dolor (A), postron forte (B), mefnac (C), positron (D), garden forte (E) were subjected to 0.1 N HCl (acidic medium), highly considerable degradation were observed in all the brands i.e. D (23.10 %), A (24.46 %), E (34.95 %), B (43.02 %) and C (66.34 %). Similarly when different brands of mefenamic acid were subjected to 0.1 N NaOH, highly considerable degradation were observed in the brand A, B (187.44 % and 124.38 %), C (51.93 %) and no degradation were observed in brand D and E (88.75 %) and (89.09 %). It is most commonly preferred as compare to other methods because of less time consuming and maintenance cost and can be use in routine quality control laboratories.
Keywords
Download Citation
Endnote/Zotero/Mendeley (RIS)BibTeX
- Y. Sun, K. Takaba, H. Kido, M.N. Nakashima and K. Nakashima, J. Pharm. Biomed. Anal., 30, 1611 (2003); doi:10.1016/S0731-7085(02)00549-6.
- V. Dokorou, Z. Ciunik, U. Russo and D. Kovala-Demertzi, J. Organomet. Chem., 630, 205 (2001); doi:10.1016/S0022-328X(01)01026-9.
- C.V. Winder, J. Wax, L. Scotti, R.A. Scherrer, E.M. Jones and F.W. Short, J. Pharmacol. Exp. Ther., 138, 405 (1962).
- E.H. Lee, S.R. Byrn and M.T. Carvajal, Pharm. Res., 23, 2375 (2006); doi:10.1007/s11095-006-9045-y.
- C.L. Viswanathan, S.K. Kulkarni and D.R. Kolwankar, AAPS Pharm. Sci. Tech., 7, E122 (2006); doi:10.1208/pt070248.
- G.A. Green, Clinical Cornerstone, 3, 50 (2001); doi:10.1016/S1098-3597(01)90069-9.
- J. Ding, X. Chen, Z. Gao, X. Dai, L. Li, C. Xie, H. Jiang, L. Zhang and D. Zhong, Drug Metabolism Deposition, 41, 1195 (2013); doi:10.1124/dmd.112.050310.
- L.K. Mannix, J. Womens Health, 17, 879 (2008); doi:10.1089/jwh.2007.0440.
- A. Pradalier, A. Clapin and J. Dry, J. Head Face Pain, 28, 550 (1988); doi:10.1111/j.1526-4610.1988.hed2808550.x.
- J. Loj and G.D. Solomon, Cleve Clin. J. Med., 73, 793 (2006).
- J.J. Werner, K. McNeill and W.A. Arnold, Chemosphere, 58, 1339 (2005); doi:10.1016/j.chemosphere.2004.10.004.
- R.K. Gilpin and W. Zhou, Vib. Spectrosc., 37, 53 (2005); doi:10.1016/j.vibspec.2004.06.001.
- S. Naveed, N. Mateen and S. Nazeer, J. Appl. Pharm., 6, 314 (2014).
- S. Naveed, S. Nazeer and N. Waheed, British J. Res., 1, 105 (2014).
- S. Naveed, S. Uroog and N. Waheed, Int. J. Curr. Pharm. Rev. Res., 5, 110 (2014).
References
Y. Sun, K. Takaba, H. Kido, M.N. Nakashima and K. Nakashima, J. Pharm. Biomed. Anal., 30, 1611 (2003); doi:10.1016/S0731-7085(02)00549-6.
V. Dokorou, Z. Ciunik, U. Russo and D. Kovala-Demertzi, J. Organomet. Chem., 630, 205 (2001); doi:10.1016/S0022-328X(01)01026-9.
C.V. Winder, J. Wax, L. Scotti, R.A. Scherrer, E.M. Jones and F.W. Short, J. Pharmacol. Exp. Ther., 138, 405 (1962).
E.H. Lee, S.R. Byrn and M.T. Carvajal, Pharm. Res., 23, 2375 (2006); doi:10.1007/s11095-006-9045-y.
C.L. Viswanathan, S.K. Kulkarni and D.R. Kolwankar, AAPS Pharm. Sci. Tech., 7, E122 (2006); doi:10.1208/pt070248.
G.A. Green, Clinical Cornerstone, 3, 50 (2001); doi:10.1016/S1098-3597(01)90069-9.
J. Ding, X. Chen, Z. Gao, X. Dai, L. Li, C. Xie, H. Jiang, L. Zhang and D. Zhong, Drug Metabolism Deposition, 41, 1195 (2013); doi:10.1124/dmd.112.050310.
L.K. Mannix, J. Womens Health, 17, 879 (2008); doi:10.1089/jwh.2007.0440.
A. Pradalier, A. Clapin and J. Dry, J. Head Face Pain, 28, 550 (1988); doi:10.1111/j.1526-4610.1988.hed2808550.x.
J. Loj and G.D. Solomon, Cleve Clin. J. Med., 73, 793 (2006).
J.J. Werner, K. McNeill and W.A. Arnold, Chemosphere, 58, 1339 (2005); doi:10.1016/j.chemosphere.2004.10.004.
R.K. Gilpin and W. Zhou, Vib. Spectrosc., 37, 53 (2005); doi:10.1016/j.vibspec.2004.06.001.
S. Naveed, N. Mateen and S. Nazeer, J. Appl. Pharm., 6, 314 (2014).
S. Naveed, S. Nazeer and N. Waheed, British J. Res., 1, 105 (2014).
S. Naveed, S. Uroog and N. Waheed, Int. J. Curr. Pharm. Rev. Res., 5, 110 (2014).